KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,467,982 | -51.8% | 160,963 | -44.1% | 0.00% | – |
| Q2 2023 | $3,044,151 | +17.9% | 287,727 | +36.3% | 0.00% | – |
| Q1 2023 | $2,581,093 | -24.6% | 211,046 | -23.5% | 0.00% | – |
| Q4 2022 | $3,422,578 | -35.8% | 275,792 | -29.4% | 0.00% | -100.0% |
| Q3 2022 | $5,334,000 | -58.2% | 390,508 | -43.9% | 0.00% | -50.0% |
| Q2 2022 | $12,753,000 | +78.3% | 695,800 | +56.4% | 0.00% | +100.0% |
| Q1 2022 | $7,154,000 | +514.1% | 444,840 | +434.1% | 0.00% | – |
| Q4 2021 | $1,165,000 | -61.4% | 83,289 | -48.3% | 0.00% | – |
| Q3 2021 | $3,015,000 | -20.3% | 161,027 | -11.3% | 0.00% | – |
| Q2 2021 | $3,785,000 | +691.8% | 181,511 | +973.9% | 0.00% | – |
| Q1 2021 | $478,000 | -76.9% | 16,902 | -73.3% | 0.00% | – |
| Q4 2020 | $2,065,000 | +305.7% | 63,240 | +280.2% | 0.00% | – |
| Q3 2020 | $509,000 | +32.6% | 16,633 | -29.4% | 0.00% | – |
| Q2 2020 | $384,000 | +163.0% | 23,558 | +60.4% | 0.00% | – |
| Q1 2020 | $146,000 | -84.6% | 14,684 | -78.7% | 0.00% | – |
| Q4 2019 | $949,000 | +124.3% | 69,081 | +148.3% | 0.00% | – |
| Q3 2019 | $423,000 | -13.8% | 27,820 | +11.6% | 0.00% | – |
| Q2 2019 | $491,000 | +46.1% | 24,928 | +23.2% | 0.00% | – |
| Q1 2019 | $336,000 | -60.3% | 20,240 | -66.5% | 0.00% | – |
| Q4 2018 | $846,000 | -12.1% | 60,328 | +9.7% | 0.00% | – |
| Q3 2018 | $963,000 | -34.0% | 55,014 | -31.4% | 0.00% | – |
| Q2 2018 | $1,460,000 | +27.5% | 80,211 | +31.5% | 0.00% | – |
| Q1 2018 | $1,145,000 | -68.7% | 61,000 | -74.5% | 0.00% | -100.0% |
| Q4 2017 | $3,663,000 | +548.3% | 239,382 | +534.0% | 0.00% | – |
| Q3 2017 | $565,000 | -89.4% | 37,756 | -93.4% | 0.00% | -100.0% |
| Q2 2017 | $5,321,000 | -29.8% | 572,223 | -33.5% | 0.00% | +100.0% |
| Q1 2017 | $7,576,000 | +310.8% | 860,856 | +175.5% | 0.00% | – |
| Q4 2016 | $1,844,000 | +4188.4% | 312,524 | +4435.9% | 0.00% | – |
| Q3 2016 | $43,000 | +975.0% | 6,890 | +330.6% | 0.00% | – |
| Q2 2016 | $4,000 | – | 1,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |